Brain, Vol. 124, No. 3, 455-456,
March 2001
© 2001 Oxford University Press
Editorial |
Risk stratification and carotid surgery: new technology but old trials
St James's University Hospital, Leeds, UK
It is now nearly a decade since evidence from the European Carotid Surgery Trial (ECST) and North American Symptomatic Carotid Endarterectomy Trial (NASCET) began to replace anecdote as the basis on which patients with high-grade symptomatic carotid stenosis could be advised about the risks and benefits of carotid endarterectomy (CEA). One remembers a certain sense of euphoria immediately after the interim results of these `positive' trials were published and it is striking how the calls to identify subgroups of patients for whom surgery might be particularly beneficial were much less strident than after the earlier `negative' Extracranial-Intracranial (EC-IC) Bypass Study
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. E Westwood, S. Kelly, E. Berry, J. M Bamford, M. J Gough, C M. Airey, J. F M Meaney, L. M Davies, J. Cullingworth, and M. A Smith Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review BMJ, January 26, 2002; 324(7331): 198 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Calamante, V. Ganesan, F.J. Kirkham, W. Jan, W.K. Chong, D.G. Gadian, and A. Connelly MR Perfusion Imaging in Moyamoya Syndrome: Potential Implications for Clinical Evaluation of Occlusive Cerebrovascular Disease Stroke, December 1, 2001; 32(12): 2810 - 2816. [Abstract] [Full Text] [PDF] |
||||

